Literature DB >> 19587000

Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation.

Eiji Tamagawa1, Koichi Suda, Yuan Wei, Li Xing, Tammy Mui, Yuexin Li, Stephan F van Eeden, S F Paul Man, Don D Sin.   

Abstract

It is widely postulated that systemic inflammation related to lung infections is largely caused by cytokine translocation from the lungs into the systemic circulation but there is a paucity of animal models to evaluate this hypothesis. In this proof-of-concept study, we developed a murine model to determine whether interleukin (IL)-6, a primary inflammatory cytokine, translocates following airway exposure to endotoxin. We collected central venous blood from the right atrium and arterial blood from the aorta simultaneously at 4 h and 24 h following intratracheal exposure to endotoxin (25 microg) and measured IL-6 in the serum and broncho-alveolar lavage (BAL) fluid (n = 33 mice). We repeated the experiment following 3 d of treatment with dexamethasone (n = 31 mice). Without stimulation, there was no significant arteriovenous gradient (3 pg/ml with interquartile range [IQR] of 3-5 pg/ml in arterial versus 18 pg/ml with IQR of 8-24 pg/ml in venous serum; P = 0.86). A significant arteriovenous difference was observed by 4 h post-exposure to endotoxin (2813 pg/ml with IQR of 1578-4316 pg/ml in arterial versus 1282 pg/ml with IQR of 778-2699 pg/ml in venous serum; P50.0001). The rise in the BAL IL-6 levels correlated with the increases in the arterial serum levels (P50.0001). Administration of intraperitoneal dexamethasone for 3 d attenuated the increased arteriovenous gradient. This murine model facilitates the estimation of cytokine translocation across the lungs and evaluation of compounds to modulate this gradient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587000     DOI: 10.1177/1753425909104782

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  12 in total

1.  Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process.

Authors:  Stephan F van Eeden; Don D Sin
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

Review 2.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

Review 3.  Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.

Authors:  Ruzena Tkacova
Journal:  Mediators Inflamm       Date:  2010-04-20       Impact factor: 4.711

4.  Differential inflammatory response to inhaled lipopolysaccharide targeted either to the airways or the alveoli in man.

Authors:  Winfried Möller; Irene Heimbeck; Thomas P J Hofer; Gülnaz Khadem Saba; Margot Neiswirth; Marion Frankenberger; Löms Ziegler-Heitbrock
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

5.  The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis.

Authors:  David A Ngan; Pearce G Wilcox; May Aldaabil; Yuexin Li; Jonathon A Leipsic; Don D Sin; S F Paul Man
Journal:  BMC Pulm Med       Date:  2012-02-14       Impact factor: 3.317

6.  Hfe deficiency impairs pulmonary neutrophil recruitment in response to inflammation.

Authors:  Karolina Benesova; Maja Vujić Spasić; Sebastian M Schaefer; Jens Stolte; Tomi Baehr-Ivacevic; Katharina Waldow; Zhe Zhou; Ursula Klingmueller; Vladimir Benes; Marcus A Mall; Martina U Muckenthaler
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

Review 7.  Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.

Authors:  Cheryl R Laratta; Stephan van Eeden
Journal:  Biomed Res Int       Date:  2014-03-02       Impact factor: 3.411

8.  Immunophenotype expressions and cytokine profiles of influenza A H1N1 virus infection in pediatric patients in 2009.

Authors:  Shih-Min Wang; Yu-Ting Liao; Yu-Shiang Hu; Tzong-Shiann Ho; Ching-Fen Shen; Jen-Ren Wang; Yee-Shin Lin; Ching-Chuan Liu
Journal:  Dis Markers       Date:  2014-02-18       Impact factor: 3.434

9.  The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.

Authors:  P Padmini S J Khedoe; Man C Wong; Gerry T M Wagenaar; Jaap J Plomp; Miranda van Eck; Louis M Havekes; Patrick C N Rensen; Pieter S Hiemstra; Jimmy F P Berbée
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

10.  Dissociation between systemic and pulmonary anti-inflammatory effects of dexamethasone in humans.

Authors:  Johann Bartko; Leopold Stiebellehner; Ulla Derhaschnig; Christian Schoergenhofer; Michael Schwameis; Helmut Prosch; Bernd Jilma
Journal:  Br J Clin Pharmacol       Date:  2016-01-15       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.